Professional Summary
Education & Certifications
- Board Certification: American Board of Nuclear Medicine, Nuclear Medicine (2012)
- Fellowship: Hospital of the University of Pennsylvania (2011) PA
- Board Certification: American Board of Radiology, Diagnostic Radiology (2010)
- Residency: Hahnemann University Hospital (2010) PA
- Residency: Hospital of the University of Pennsylvania (2007) PA
- Internship: Greater Baltimore Medical Center (2006) MD
- Medical Education: Topiwala National Medical College, University of Mumbai (2002) India
Publications
-
Confirmation of Ectopic Pancreatic Tissue: A Novel Use for 18F-Fluciclovine PET.
Keller, E. J., de Castro, C. M., Ghanouni, P., & Shah, J. (2022). Confirmation of Ectopic Pancreatic Tissue: A Novel Use for 18F-Fluciclovine PET. Clinical Nuclear Medicine. -
SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting.
Song, H., Ferri, V., Duan, H., Aparici, C. M., Davidzon, G., Franc, B. L., … Iagaru, A. (2023). SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting. European Journal of Nuclear Medicine and Molecular Imaging. -
A Case-Based Primer on FDG PET/CT for Imaging Cardiovascular Infections: Protocol, Interpretation, and Pitfalls.
Zhou, W., Moradi, F., Davidzon, G., Song, H., Grady, E., Nguyen, J., … Shah, J. (2023). A Case-Based Primer on FDG PET/CT for Imaging Cardiovascular Infections: Protocol, Interpretation, and Pitfalls. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
Khessib, T., Jha, P., Davidzon, G. A., Iagaru, A., & Shah, J. (2024). Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review. Seminars in Nuclear Medicine. -
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.
Song, H., Leonio, M. I., Ferri, V., Duan, H., Aparici, C. M., Davidzon, G., … Iagaru, A. (2024). Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
SHC- Nuclear Medicine (300P) Stanford, CA
Stanford, CAReferring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology orders
- View referral status
- Access medical records